Drug Topics

DECEMBER 30, 2022

New research indicates that inflammatory bowel disease (IBD) risk could be moderated by a healthy lifestyle.

195

195

IDStewardship

DECEMBER 30, 2022

On this webpage the Learn Antibiotics book is described. Where Can I Find The Learn Antibiotics Book? The Learn Antibiotics Book is currently available on Amazon and can be found here. Beware there has been at least one fake listing of the book on Amazon, which has been flagged for removal. Make sure to pick the listing that has Timothy P. Gauthier as the author.

130

130

Drug Topics

DECEMBER 30, 2022

Take a look back at the top 15 articles that we published in 2022.

183

183

STAT

DECEMBER 30, 2022

The number of young people in the U.S. with type 2 diabetes could surge by about 700% over the next four decades, with a greater burden falling on minority groups, a new model predicts. If the recent acceleration of new diagnoses persists, then 220,000 people younger than 20 would have type 2 diabetes in 2060, compared with 28,000 in 2017, the latest year for which data is available, according to projections published this month in Diabetes Care.

111

111

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

DECEMBER 30, 2022

Take a look back at our most popular news from December 2022.

187

187

STAT

DECEMBER 30, 2022

Francesca Coleman, known to friends as “St. Louis,” has been unhoused since the age of 15. Now 24, Coleman sleeps in Tongva park, across from the famous Santa Monica pier in California. Like many unhoused people in the Los Angeles area, Coleman uses meth in an attempt to ease chronic pain, anxiety, and depression. On a Wednesday morning in July, physician Coley King checked in with Coleman in Tongva Park.

104

104

STAT

DECEMBER 30, 2022

This year, STAT deepened its footholds in a number of coverage areas, from hospitals and insurance to reproductive health to health tech. Our staff also looked with admiration — and some envy — to many other journalists doing great reporting in these spaces. Below is our annual list of STAT staffers’ favorite stories of the year, and that we wish we had written.

Insurance 98

Insurance Hospitals 98

pharmaphorum

DECEMBER 30, 2022

The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to the community, according to a new survey of 200 GPs in the UK. Just 4% of would choose the hospital as the preferred location of testing, compared to 46% for the GP surgery, 18% for a community hub, 15% for a patient’s home and 12% for the pharmacy.

Nursing Homes 98

Nursing Homes Patient Care Hospitals 98

STAT

DECEMBER 30, 2022

The Food and Drug Administration’s approval of Wegovy, Novo Nordisk’s latest obesity drug, for adolescents aged 12 years and older opens up a highly-anticipated tool in the fight against childhood obesity, but some doctors warn the sought-after medication isn’t a magic bullet. The move comes after the FDA approved Wegovy (semaglutide) for weight management in adults in 2021.

FDA 98

FDA 98

Pharmacy Times

DECEMBER 30, 2022

This month's clinical pharmacology update looks at a medication to manage Helicobacter pylori infection in adults.

152

152

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

DECEMBER 30, 2022

Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and what specifically had attracted Verheul to attend. Chatting about Graphite Digital’s role as a design specialist for HCPs, patient groups, and ‘everything in between’ – the vision and purpose that encircles that – Verheul and I look at the conversations being sparked at the event, the challenges that are clear across industries

97

97

Pharmacy Times

DECEMBER 30, 2022

New drug approvals, toxicity management, and pharmacists’ roles in cancer care all dominated the top oncology articles of 2022.

94

94

pharmaphorum

DECEMBER 30, 2022

The FDA’s interactions with Biogen in the build-up to last year’s controversial approval of Alzheimer’s disease therapy Aduhelm have been described as “inappropriate” and “atypical” in a congressional report on the review. The document produced by Oversight and Reform Committee chair Carolyn Maloney (D-NY) and Energy and Commerce Committee chair Frank Pallone Jr (D-NJ) also points to “collaboration” between Biogen and the FDA ahead of an advi

FDA 59

FDA Documentation Labelling 59

Pharmacy Times

DECEMBER 30, 2022

Products include the generic alternatives to Esbriet and Oracea.

121

121

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmExec

DECEMBER 30, 2022

AI continued to grow over the last year, and more life sciences companies are embracing the new technology in a variety of ways.

52

52

Pharmaceutical Commerce

DECEMBER 30, 2022

The latest people news happenings over the past month.

52

52

STAT

DECEMBER 30, 2022

Health care providers are swamping the government with billing disputes under the new law that bans surprise medical bills. So far, just 4% have ended in payment.  That’s according to the Biden administration’s progress report on the No Surprises Act’s so-called independent dispute resolution (IDR) process, in which mediators help out-of-network providers and insurers decide appropriate payment amounts for services.

Insurance 100

Insurance 100